Prexton therapeutics

Prexton therapeutics

Integrates molecular, behavioral and chemistry technologies to address Parkinson’s disease and other brain disorders. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD1.5b (Public information from Mar 2018)
Company register number 67516114
Oss Noord-Brabant (HQ)
Authorizing premium user...